Resonance Health
You have no credits left. To view this article subscribe to Business News.
You have used {{points}} and have {{current_points}} remaining. Your credits will reset on {{reset_date}}.
This article is part of a special report and is available to paid Business News subscribers only.
You can purchase access to this special report or subscribe to Business News.
You can purchase access to this special report or subscribe to Business News.
This article is premium content and is available to paid Business News subscribers only.
Subscribe to Business News.
Subscribe to Business News.
Tuesday, 23 August, 2005 - 22:00
Resonance Health 16-Aug-05 Subsidiary Resonance Health Analysis Services has signed an agreement with the New England Research Institutes to provide FerriScan® as part of clinical trials into the iron loading disorder thalassemia.